AD

Anjali Dixit

Active Director Director DIN 09047624
DIN 09047624 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Anjali Dixit

Data last updated:

Anjali Dixit is a Director at Urmicos Biotech Private Limited (since 2021). The company operates in Trading. Urmicos Biotech Private Limited reported revenue of ₹96.5 Lakh (FY 2025).

DIN 09047624
Primary Designation Director
Industry Trading
First Appointment 01 Feb 2021
Oldest Company Age 5 yrs
Largest company Urmicos Biotech Private Limited · ₹96.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Urmicos Biotech Private Limited U51909MP2021PTC054696
Director01 Feb 20212021₹96.5 Lakh (FY 2025)Active

Board colleagues of Anjali Dixit

NameDINCompanyDesignation
Anand Dixit03146304Urmicos Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Urmicos Biotech Private Limited
Premium access

Shareholding and investment profile for Anjali Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Dixit

Anjali Dixit currently holds 1 directorship: Urmicos Biotech Private Limited (Director, since 01 Feb 2021, revenue ₹96.5 Lakh (FY 2025)).

Anjali Dixit was first appointed on 01 Feb 2021 as Director at Urmicos Biotech Private Limited.

The current boards of Anjali Dixit's companies include Anand Dixit (Urmicos Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available